[EN] PYRANOPYRAZOLE AND PYRAZOLOPYRIDINE IMMUNOMODULATORS FOR TREATMENT OF AUTOIMMUNE DISEASES [FR] IMMUNOMODULATEURS À BASE DE PYRANOPYRAZOLE ET DE PYRAZOLOPYRIDINE POUR LE TRAITEMENT DE MALADIES AUTO-IMMUNES
Pyranopyrazole and pyrazolopyridine immunomodulators for treatment of autoimmune diseases
申请人:The Rockefeller University
公开号:US11312723B2
公开(公告)日:2022-04-26
Pyranoyrazoles and pyrazolopyridines of formula I or formula II are disclosed:
These compounds inhibit Coagulation Factor XIIa in the presence of thrombin and other coagulation factors. They are useful to treat autoimmune diseases.
公开了式 I 或式 II 的吡喃并吡唑和吡唑并吡啶:
这些化合物在凝血酶和其他凝血因子存在的情况下抑制凝血因子 XIIa。它们可用于治疗自身免疫性疾病。
PYRANOPYRAZOLE AND PYRAZOLOPYRIDINE IMMUNOMODULATORS FOR TREATMENT OF AUTOIMMUNE DISEASES
申请人:The Rockefeller University
公开号:EP3716972A1
公开(公告)日:2020-10-07
INDOLE AHR INHIBITORS AND USES THEREOF
申请人:Ikena Oncology, Inc.
公开号:US20220144839A1
公开(公告)日:2022-05-12
The present invention provides compounds useful as inhibitors of AHR, compositions thereof, and methods of using the same.
[EN] INDOLE AHR INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS D'INDOLE AHR ET LEURS UTILISATIONS
申请人:IKENA ONCOLOGY INC
公开号:WO2020081636A1
公开(公告)日:2020-04-23
The present invention provides compounds useful as inhibitors of AHR, compositions thereof, and methods of using the same.